Current Medical Research and Opinion Current Medical Research and Opinion RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Guest editor foreword: real-world evidence and medical affairs
Curr Med Res Opin. 2023 Dec 3:1-3. doi: 10.1080/03007995.2023.2286091. Online ahead of print.NO ABSTRACTPMID:38044635 | DOI:10.1080/03007995.2023.2286091 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - December 4, 2023 Category: Research Authors: Ravi Jandhyala Source Type: research

Editor-in-Chief Foreword: can we engage in evidence-based medicine by using practice-based evidence?
Curr Med Res Opin. 2023 Dec 2:1-2. doi: 10.1080/03007995.2023.2287865. Online ahead of print.NO ABSTRACTPMID:38041563 | DOI:10.1080/03007995.2023.2287865 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - December 2, 2023 Category: Research Authors: Leslie Citrome Source Type: research

Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults
CONCLUSIONS: There are gaps in awareness of MenB disease, vaccination, and SCDM among parents and patients in the US, resulting in missed opportunities for discussing and administering MenB vaccination. Targeted education on MenB and vaccination recommendations may increase these opportunities and improve MenB vaccination awareness and initiation.PMID:38032143 | DOI:10.1080/03007995.2023.2285366 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - November 30, 2023 Category: Research Authors: Oscar Herrera-Restrepo Zifan Zhou Annie Krishnan Wanda J Conley Eni Oladele Jasjit K Multani Rifat Tuly Liucheng Shi Chi-Chang Chen Scott Preiss Diana E Clements Source Type: research

Artificial Intelligence and the potential for Garbage In, Garbage Out
Curr Med Res Opin. 2023 Nov 29:1-2. doi: 10.1080/03007995.2023.2286785. Online ahead of print.NO ABSTRACTPMID:38030564 | DOI:10.1080/03007995.2023.2286785 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - November 29, 2023 Category: Research Authors: Leslie Citrome Source Type: research

The effects of COVID-19 infection on working memory: a systematic review
Conclusion：COVID-19 can cause a decline in working memory ability, accompanied by neurological symptoms.However, there is a lack of studies to identify the structural and functional changes in specific brain regions that related to the impaired working memory.PMID:38008952 | DOI:10.1080/03007995.2023.2286312 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - November 27, 2023 Category: Research Authors: Rui Cui BeiYao Gao RuiDong Ge MingZhen Li Min Li Xi Lu Shan Jiang Source Type: research

Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review
Curr Med Res Opin. 2023 Nov 25:1-24. doi: 10.1080/03007995.2023.2288909. Online ahead of print.ABSTRACTBudd-Chiari syndrome (BCS) and sinusoidal obstruction syndrome (SOS) are two major vascular disorders of the liver, of which both can cause portal hypertension related complications, but their locations of obstruction are different. BCS refers to the obstruction from the hepatic vein to the junction between inferior vena cava and right atrium, which is the major etiology of post-sinusoidal portal hypertension; by comparison, SOS is characterized as the obstruction at the level of hepatic sinusoids and terminal venular, wh...
Source: Current Medical Research and Opinion - November 25, 2023 Category: Research Authors: Feifei Lu Siqi Jia Huiyuan Lu Haonan Zhao Zhe Li Yuzheng Zhuge Fernando Gomes Romeiro Nahum Mendez-Sanchez Xingshun Qi Source Type: research

Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis
CONCLUSIONS: Apremilast and deucravacitinib are effective for scalp psoriasis. Deucravacitinib may be more efficient in clearing the scalp.PMID:37997745 | DOI:10.1080/03007995.2023.2288280 (Source: Current Medical Research and Opinion)
Source: Current Medical Research and Opinion - November 24, 2023 Category: Research Authors: Sotirios G Tsiogkas Eleni K Karamitrou Maria G Grammatikopoulou Efterpi Zafiriou Dimitrios P Bogdanos Source Type: research

Aripiprazole 2-month ready-to-use 960  mg (Ari 2MRTU): review of its possible role in schizophrenia therapy
Curr Med Res Opin. 2023 Nov 24:1-23. doi: 10.1080/03007995.2023.2287612. Online ahead of print.ABSTRACTMost patients with schizophrenia need life-long treatment. There is therefore a continued need for effective and tolerable treatment options. A 2-monthly LAI formulation of aripiprazole, Aripiprazole 2-Month Ready-to-Use 960 mg (Ari 2MRTU 960) has recently been approved in the U.S. Here, the possible role in therapy for this new treatment option is discussed in a narrative review. PubMed was searched for literature on long-acting injectables with a focus on patient-reported outcomes and real-world evidence on extended inj...
Source: Current Medical Research and Opinion - November 24, 2023 Category: Research Authors: Bernhard T Baune Source Type: research